Table 4.
Clinical features of patients included in deriving hepatic organoid lines.
| Organoids | Sex | Age | Reason of Surgery | Serum AAT | GPT | GOT | GGT | Platelets | Glucose | Albumin | Bilirubin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | (Years) | (g/L) | (U/L) | (U/L) | (U/L) | (×1000/uL) | (mg/dL) | (g/dL) | (mg/dL) | ||
| (5–45) * | (5–33) * | (8–61) * | (140–450) * | (70–110) * | (3.5–5) * | (0.2–1) * | |||||
| MM | F | 78 | Hepatocellular carcinoma | ND | 31 | 31 | 49 | 246 | 113 | 4.5 | 0.3 |
| MZ | M | 82 | Cholecystectomy | ND | 64 | 36 | 33 | 126 | 110 | 3.9 | 0.3 |
| ZZ | M | 1 | Hepatic failure. Liver transplant | 0.41 | 199 | 360 | 551 | 92 | 71 | 3 | 3.67 |
* Range of normal values.; ND: non-determined.